Nanotech Safety, Efficacy Models Exist, But Nomenclature Problematic – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA expects nanotechnology will be subject to the same efficacy standards demanded of medical devices, according to CDRH Office of Science & Engineering Laboratories Director Larry Kessler